BREAST CANCER

Refine Results:
All Categories Epidemiology and Etiology (635) Prevention and Screening (474) Diagnosis and Staging (729) Treatment (1598) Supportive Oncology (178)

CME

CaseLine: HER2-Positive Breast Cancer
An interactive CME program provided by Educational Concepts Group, LLC
OncologySTAT CME
Monica Visit 2: A 36-Year-Old Female with Early Stage Breast Cancer, Returning for Follow-up
An interactive CME program powered by Real CME
OncologySTAT CME
Clinically Challenging Case Series: Breast Cancer-Related Bone Disease
OncologySTAT CME
Monica Visit 1: A 36-Year-Old Female with Early Stage Breast Cancer
An interactive CME program powered by Real CME
OncologySTAT CME

News

Breast Brachytherapy Judged Superior in Tumor Bed Control
Elsevier Global Medical News, 2012 May 10, ME Tucker
Surgery for DCIS Saves Lives
Elsevier Global Medical News, 2012 May 7, N Osterweil
Radiofrequency Ablation Advances as Radiation Alternative in Breast Cancer
Elsevier Global Medical News, 2012 May 7, ME Tucker
Infrared Thermography Fails to Predict Breast Malignancy
Elsevier Global Medical News, 2012 May 4, ME Tucker
Breast Cancer More Lethal in Men
Elsevier Global Medical News, 2012 May 4, ME Tucker
More News ›

Journal Scans: Research

Brachytherapy Associated With Increased Complications Compared to Whole-Breast Irradiation Following Lumpectomy for Breast Cancer
JAMA, 2012 May 1, GL Smith, et al
EXPERT COMMENTARY
Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation Carriers
J Natl Cancer Inst, 2012 Apr 24, B Mukherjee, et al
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
J Clin Oncol, 2012 Apr 19, G von Minckwitz, et al
EXPERT COMMENTARY
Standardized Uptake Value by Positron Emission Tomography/Computed Tomography as a Prognostic Variable in Metastatic Breast Cancer
Cancer, 2012 Apr 19, PG Morris, et al
The Effect of DCIS Grade on Rate, Type and Time to Recurrence After 15 Years of Follow-Up of Screen-Detected DCIS
Br J Cancer, 2012 Apr 19, MG Wallis, et al
EXPERT COMMENTARY
More Journal Scans: Research ›

Journal Scans: Review

Bisphosphonate-Related Osteonecrosis of the Jaws – A Review
Oral Oncol, 2012 Apr 23, S Kuhl, et al
Free Journal Content
Systemic Therapy for Bone Metastases
Cancer Control, 2012 Apr 19, LS Loftus, et al
Free Journal Content
Targeted Agents to Reverse Resistance to Endocrine Therapy in Metastatic Breast Cancer: Where Are We Now and Where Are We Going?
Crit Rev Oncol Hematol, 2012 Apr 12, P Fedele, et al
Free Journal Content
mTOR Signaling Pathway and mTOR Inhibitors in Cancer Therapy
Hematol Oncol Clin North Am, 2012 Apr 5, A Gomez-Pinillos, et al
Free Journal Content
Management of Elderly Patients With Breast Cancer: Updated Recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Lancet Oncol, 2012 Apr 1, L Biganzoli, et al
More Journal Scans: Review ›

Expert Opinion

Antiangiogenic Therapy In Breast Cancer—What We Know and What We Don't
Interview by L Scott Zoeller, 2012 May 2, Kathy Miller, et al
Long-Term Outcome of Breast Conserving Therapy
Lancet Oncol, 2012 Apr 1, JR Benson
Free Journal Content
Inflammatory HER2-Positive Breast Cancer
Lancet Oncol, 2012 Apr 1, LY Dirix, et al
Free Journal Content
Aromatase Inhibitors and Musculoskeletal Adverse Events
Lancet Oncol, 2012 Apr 1, PER Liedke, et al
Free Journal Content
Standardisation of Clinical Breast-Density Measurement
Lancet Oncol, 2012 Apr 1, K-H Ng, et al
Free Journal Content
More Expert Opinion ›

Chemotherapy Regimens

Hormone therapy (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Trastuzumab, vinorelbine (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TH (paclitaxel, trastuzumab [Herceptin])
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TC (docetaxel, cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TAC (doxetaxel, doxorubicin [Adriamycin], cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Conference Coverage

2011 San Antonio Breast Cancer Symposium
Dec 6-10 2011 San Antonio, et al
2011 Breast Cancer Symposium
Sept 8-10 2011 San Francisco, et al

Videos

Highlights of European Breast Cancer Conference
EJC News Focus, 2012 May 1
Plan to Attend 2013 Community Oncology Conference
Elsevier Global Medical News, 2012 Apr 2
What Matters: Bisphosphonates as Anti-Tumor Agents in Early-Stage Breast Cancer
Elsevier Global Medical News, 2012 Jan 6
Do Bisphosphonates Reduce Cancer Risk?
Elsevier Global Medical News, 2012 Jan 5
Targeted Agent Combos May Be the Way in Breast Cancer
EJC News Focus, 2012 Jan 1
More Videos ›

Summary of Key Points

Cancer of the Breast
Abeloff's Clinical Oncology, 4th ed. 2008

Updated Key Points: Breast Cancer

Summary information about breast cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›

Editors' Choice

Establishing Standard Care in Advanced Adrenocortical Carcinoma
Read more ›

Commentary

Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration